Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3017190736;90737;90738 chr2:178552389;178552388;178552387chr2:179417116;179417115;179417114
N2AB2853085813;85814;85815 chr2:178552389;178552388;178552387chr2:179417116;179417115;179417114
N2A2760383032;83033;83034 chr2:178552389;178552388;178552387chr2:179417116;179417115;179417114
N2B2110663541;63542;63543 chr2:178552389;178552388;178552387chr2:179417116;179417115;179417114
Novex-12123163916;63917;63918 chr2:178552389;178552388;178552387chr2:179417116;179417115;179417114
Novex-22129864117;64118;64119 chr2:178552389;178552388;178552387chr2:179417116;179417115;179417114
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCA
  • RefSeq wild type template codon: GGT
  • Domain: Ig-148
  • Domain position: 40
  • Structural Position: 56
  • Q(SASA): 0.4874
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/L rs2154151253 None 0.984 D 0.677 0.455 0.721402755317 gnomAD-4.0.0 3.30137E-06 None None None None N None 0 0 None 0 0 None 0 0 2.96937E-06 1.51713E-05 0
P/T None None 0.999 D 0.717 0.442 0.610711448424 gnomAD-4.0.0 6.95148E-07 None None None None N None 0 0 None 0 0 None 0 0 9.1041E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.0991 likely_benign 0.0929 benign -0.544 Destabilizing 0.992 D 0.65 neutral D 0.525997499 None None N
P/C 0.5868 likely_pathogenic 0.549 ambiguous -0.663 Destabilizing 1.0 D 0.734 prob.delet. None None None None N
P/D 0.6653 likely_pathogenic 0.5382 ambiguous -0.33 Destabilizing 1.0 D 0.755 deleterious None None None None N
P/E 0.4656 ambiguous 0.3509 ambiguous -0.413 Destabilizing 1.0 D 0.76 deleterious None None None None N
P/F 0.513 ambiguous 0.4548 ambiguous -0.613 Destabilizing 1.0 D 0.749 deleterious None None None None N
P/G 0.481 ambiguous 0.4156 ambiguous -0.701 Destabilizing 1.0 D 0.729 prob.delet. None None None None N
P/H 0.2631 likely_benign 0.2183 benign -0.147 Destabilizing 1.0 D 0.715 prob.delet. None None None None N
P/I 0.2425 likely_benign 0.2235 benign -0.264 Destabilizing 0.919 D 0.501 neutral None None None None N
P/K 0.4781 ambiguous 0.3704 ambiguous -0.536 Destabilizing 1.0 D 0.754 deleterious None None None None N
P/L 0.1105 likely_benign 0.1073 benign -0.264 Destabilizing 0.984 D 0.677 prob.neutral D 0.526517574 None None N
P/M 0.3127 likely_benign 0.2951 benign -0.454 Destabilizing 1.0 D 0.721 prob.delet. None None None None N
P/N 0.4345 ambiguous 0.3754 ambiguous -0.334 Destabilizing 1.0 D 0.73 prob.delet. None None None None N
P/Q 0.2175 likely_benign 0.1857 benign -0.531 Destabilizing 1.0 D 0.741 deleterious N 0.486947004 None None N
P/R 0.3387 likely_benign 0.2535 benign -0.024 Destabilizing 1.0 D 0.732 prob.delet. N 0.497253353 None None N
P/S 0.1946 likely_benign 0.168 benign -0.707 Destabilizing 1.0 D 0.747 deleterious D 0.529595164 None None N
P/T 0.1493 likely_benign 0.1307 benign -0.687 Destabilizing 0.999 D 0.717 prob.delet. D 0.534598339 None None N
P/V 0.1677 likely_benign 0.161 benign -0.323 Destabilizing 0.988 D 0.629 neutral None None None None N
P/W 0.7629 likely_pathogenic 0.7065 pathogenic -0.711 Destabilizing 1.0 D 0.735 prob.delet. None None None None N
P/Y 0.4998 ambiguous 0.4295 ambiguous -0.423 Destabilizing 1.0 D 0.743 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.